Drug formularies may cover GLP-1 agonists prescribed for Type 2 diabetes but not for weight loss
As the world grapples with medication shortages and the environmental impact of pharmaceutical production, the Phytogene platform offers a promising solution
As was previously demonstrated for a sublingual insulin formulation (sublintherapeutics.com/sublin-bv-developing-a-first-in-class-sublingual-insulin-delivery-formulation/)), these in vivo incretin studies clearly show that the sublingual formulation technology can incorporate different drug classes and provide an effective alternative for patients to their daily injections
Wu X, Han T, Gao J, Zhang Y, Zhao S, Sun R, et al
doi: 10.3390/metabo11030155, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 241
By understanding the normal cycles of a weight loss journey, it becomes possible to turn this frustrating moment into an opportunity to fine-tune your approach and continue moving toward your long-term health goals with confidence
